Industry reports
Editor highlights

Acrux Gets European Backing for Dog Drug Treatment

  • Currently 0/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
0 review
Recuvyra is a skin solution for dogs that controls pain after orthopedic and soft tissue surgery. (Photo: Luca Zaninoni)
Recuvyra is a skin solution for dogs that controls pain after orthopedic and soft tissue surgery. (Photo: Luca Zaninoni)

BUSINESS

  • Acrux receives approval in Europe for Recuvyra, a pain-relieving transdermal solution for dogs
  • Recuvyra is the latest product to be developed under license by Elanco
  • Eli Lilly holds the exclusive licence to commercialize and develop Acrux’s transdermal animal health products

Australian drug delivery company Acrux has received support from European medical authorities for its first animal health product.

The European Committee for Medicinal Products for Veterinary Use (CVMP) granted marketing authorization for the drug Recuvyra, a skin solution for dogs containing the active ingredient Fentanyl that controls pain after orthopedic and soft tissue surgery.

The solution was developed under license by the animal health unit of pharmaceutical giant Eli Lilly and Company, called Elanco.

Continued Cooperation with Eli Lilly

Upon approval of the marketing authorization, Acrux will receive an initial payment of AU$500,000 from the CVMP and will be entitled to royalties on product sales.

Drug giant Eli Lilly holds the exclusive licence to commercialize and develop Acrux’s transdermal animal health products. Recuvyra is expected to receive marketing authorization within 90 days.

The dog treatment’s launch in Europe will be the latest drug product from Eli Lilly and Acrux, after last year’s release of the topical male testosterone solution Axiron.

“Following the recent launch by Lilly of Axiron in the United States, this adds further momentum to Acrux’s partnership with Lilly,” said Richard Treagus, Acrux CEO.

Key Players – Veterinary Health Market

  • Abaxis, Alpharma, BASF, Bayer Animal Health, Biocurex, BioVet, Boehringer Ingelheim, Elanco Animal Health, Janssen Pharmaceutica, Merck, Neogen Corporation, Novartis Animal Health, PETCO Animal Supplies, Pfizer Animal Health, Randox, Sanofi-Aventis, Teva Pharmaceutical Industries

By James Mulholland for
James Mulholland is a Paris-based internet and broadcast journalist specializing in sports, current affairs and technology news, while also freelancing as a photographer.

Share this news with a friend or colleague

Share

Follow

Browse our categories

Browse our archives

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.